Please assess the completion status of the following clinical trial:

Trial Title: Androgen Effect on Klinefelter Syndrome Motor Outcome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Karyotype diagnosis of Klinefelter syndrome~* Chronological age of 4-12 years~* No treatment with androgen in the past year~Exclusion Criteria:~* Major liver, kidney or other systemic disease~* Variant karyotypes including 47,XYY males~* Evidence of spontaneous onset of puberty, defined as testicular size \> 4ml

- Gender: MALE
- Minimum Age: 4 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Oxandrolone (Type: ACTIVE_COMPARATOR): Androgen oxandrolone: Oxandrolone, 0.6 \> mg/kg/day, orally, for 2 years.
- Placebo (Type: PLACEBO_COMPARATOR): An inactive substance.

Based on this trial design, predict the completion outcome and termination type (if applicable).